Statement | 24 May 2013 Research and development MSF intervention on R&D Financing & Coordination at 66th WHA 3 min
Statement | 22 May 2013 Research and development MSF intervention on WHO reform at 66th World Health Assembly
Statement | 24 April 2013 Intellectual property and trade Vaccines MSF statement on GAVI's response to 'Dear GAVI' campaign
Statement | 18 April 2013 Vaccines MSF responds to Decade of Vaccines supplement launch in the journal VACCINES
Statement Statement | 04 March 2013 Intellectual property and trade India India upholds compulsory licence on cancer drug in Bayer case appeal
Statement | 16 January 2013 HIV/AIDS MSF addresses study by Massachusetts General Hospital on implications of switching from branded to generic antiretrovirals for HIV 4 min
Statement | 22 November 2012 Intellectual property and trade Why Roche can decrease its prices and why it has a moral obligation to do so
